These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12903615)

  • 1. [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult].
    Mori S; Apice G; Ottaiano A; De Chiara A; Germano A; Botti G; De Rosa V; Ravo V; Morrica B; Mozzillo N
    Tumori; 2003; 89(4 Suppl):267-8. PubMed ID: 12903615
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy for intermediate/high-grade soft tissue sarcomas: five-year results with epirubicin and ifosfamide.
    Ottaiano A; De Chiara A; Fazioli F; De Rosa V; Ravo V; Boccia V; Botti G; Petrillo A; Fiore F; Mori S; Mozzillo N; Iaffaioli VR; Apice G
    Anticancer Res; 2002; 22(6B):3555-9. PubMed ID: 12552955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
    Tanaka K; Ozaki T
    Jpn J Clin Oncol; 2021 Feb; 51(2):180-184. PubMed ID: 33313851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.
    Frustaci S; Gherlinzoni F; De Paoli A; Bonetti M; Azzarelli A; Comandone A; Olmi P; Buonadonna A; Pignatti G; Barbieri E; Apice G; Zmerly H; Serraino D; Picci P
    J Clin Oncol; 2001 Mar; 19(5):1238-47. PubMed ID: 11230464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.
    O'Donnell PW; Manivel JC; Cheng EY; Clohisy DR
    Clin Orthop Relat Res; 2014 Mar; 472(3):849-55. PubMed ID: 23640206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant chemotherapy of soft tissue sarcoma].
    Lévy E; Thirion P; Piedbois P
    Cancer Radiother; 1997; 1(5):462-6. PubMed ID: 9587378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD; Elias AD
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
    Casali P; Pastorino U; Zucchinelli P; Devizzi L; Azzarelli A; Quagliuolo V; Bignami P; Santoro A; Bonadonna G
    Ann Oncol; 1992 Apr; 3 Suppl 2():S125-6. PubMed ID: 1622854
    [No Abstract]   [Full Text] [Related]  

  • 9. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas.
    Ryan CW; Montag AG; Hosenpud JR; Samuels B; Hayden JB; Hung AY; Mansoor A; Peabody TD; Mundt AJ; Undevia S
    Cancer; 2008 Jun; 112(11):2432-9. PubMed ID: 18348295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk.
    Gronchi A; Jones RL
    JAMA Oncol; 2018 Sep; 4(9):1167-1168. PubMed ID: 29879269
    [No Abstract]   [Full Text] [Related]  

  • 11. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas.
    Walter AW; Shearer PD; Pappo AS; Greenwald CA; Rao BN; Bowman LC; Furman WL; Gajjar A; Jenkins JJ; Pratt CB
    Med Pediatr Oncol; 1998 Apr; 30(4):210-6. PubMed ID: 9473755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
    Wang B; Yu X; Xu S; Xu M
    Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.
    Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
    BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.
    Palassini E; Ferrari S; Verderio P; De Paoli A; Martin Broto J; Quagliuolo V; Comandone A; Sangalli C; Palmerini E; Lopez-Pousa A; De Sanctis R; Bottelli S; Libertini M; Picci P; Casali PG; Gronchi A
    J Clin Oncol; 2015 Nov; 33(31):3628-34. PubMed ID: 26351345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical therapy in paediatric soft tissue tumors].
    Orbach D; Levy D; Héritier S; Normand C
    Arch Pediatr; 2010 Jun; 17(6):719-20. PubMed ID: 20654858
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.
    Eilber FC; Rosen G; Eckardt J; Forscher C; Nelson SD; Selch M; Dorey F; Eilber FR
    J Clin Oncol; 2001 Jul; 19(13):3203-9. PubMed ID: 11432887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
    Bokemeyer C; Harstrick A; Schmoll HJ; Köhne-Wömpner CH; Schöffski P; Poliwoda H
    Ann Oncol; 1992 Jun; 3(6):487-8. PubMed ID: 1498067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma.
    Petrioli R; Coratti A; Correale P; D'Aniello C; Grimaldi L; Tanzini G; Civitelli S; Marsili S; Messinese S; Marzocca G; Pirtoli L; Francini G
    Am J Clin Oncol; 2002 Oct; 25(5):468-73. PubMed ID: 12393986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.